Phase I trial of PBT434 in patients with atypical Parkinsonian disease

Trial Profile

Phase I trial of PBT434 in patients with atypical Parkinsonian disease

Planning
Phase of Trial: Phase I

Latest Information Update: 05 Jul 2017

At a glance

  • Drugs PBT 434 (Primary)
  • Indications Parkinson's disease
  • Focus Adverse reactions; First in man; Pharmacodynamics; Pharmacokinetics
  • Sponsors Prana Biotechnology
  • Most Recent Events

    • 05 Jul 2017 According to a Prana Biotechnology media release, PBT434 is expected to begin human testing in a Phase 1 trial later in 2017.
    • 01 Mar 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top